Monte Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.11M Buy
94,960
+36,975
+64% +$2.98M 2.6% 6
2026
Q1
$5.02M Buy
57,985
+15,677
+37% +$1.5M 1.78% 28
2025
Q4
$4.06M Sell
42,308
-360
-0.8% -$35K 1.51% 34
2025
Q3
$4.06M Buy
42,668
+10,546
+33% +$969K 1.49% 35
2025
Q2
$2.8M Buy
+32,122
New +$2.72M 1.09% 35
2021
Q4
Sell
-27,374
Closed -$3.43M 74
2021
Q3
$3.43M Buy
27,374
+286
+1% +$37K 1.97% 29
2021
Q2
$3.36M Buy
27,088
+7,181
+36% +$902K 1.92% 30
2021
Q1
$2.35M Buy
+19,907
New +$2.33M 1.44% 32

Other funds holding MDT

Monte Financial Group's MDT Position: Q2 2026 in Review

Monte Financial Group increased its Medtronic (MDT) stake by 64% in Q2 2026, buying an estimated $2.98M and bringing the position to 94,960 shares worth $8.11M. The position accounts for 2.6% of the portfolio, ranked #6.

Monte Financial Group first reported a position in MDT in Q1 2021 and has held it in 8 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Monte Financial Group held 94,960 shares of Medtronic worth $8.11M as of Q2 2026.
  • Monte Financial Group bought 36,975 Medtronic shares in Q2 2026, an estimated $2.98M.
  • Medtronic made up 2.6% of Monte Financial Group's portfolio in Q2 2026, its #6 holding.
  • Monte Financial Group first reported a position in Medtronic in Q1 2021 and has held it in 8 quarters since.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Monte Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.